XBI — All updates

7 entries loaded; 1 direction changes

Filter loaded records
StockCharts TVPublished 2026-11-17
“The Market Has Changed. Here's What I'm Waiting For”
$XBIBearish
AI summary · After leading during the upsurge with a strong move, a bought pullback and a new all-time high, XBI's attempt at a bullish 'cup and handle' pattern fell short. The failed breakout created a major lower high, making price action since June look like a potentially large head-and-shoulders pattern, which clearly presents a challenge.

Now, the biotechnology sector was one of the best performing sectors, especially XBI during the upsurge, was n't it? Strong move, pullback bought, another new all-time high, and recently attempted to form a bullish "cup and handle" pattern as well . He couldn't get there exactly.

Brian ShannonPublished 2026-11-13
“Stock Market, Bitcoin & Gold Analysis 11/13/26”
$XBINo side taken
AI summary · XBI's 50-day moving average is trending down; lower peaks could turn around only if it flattens. Biotech relative strength—falling less than the market—helps predict next moves but is not a reason to buy. The speaker's preferred scenario, not a prediction, is a breakdown to test or break the 200-day moving average and the year-to-date pivot, then a bear trap and rebound building for another upward push by year-end.

Biotechnology has a 50-day moving average in a downward trend. This is a group with potential , you know, it has relative strength. amazing. Amazing. Relative strength means that it does not break down with the market, i.e., it does not fall as much as the rest of the market.

It is cohesive. Well, you don't make profits from simply holding on. You profit from absolute power. Relative strength is good for predicting what might happen next, but it is not a reason to buy.

We have, as I have indicated here, these lower peaks. It appeared to have the potential to turn around if it did something like that, because the 50-day moving average would start to flatten out.

Last week I reviewed this possible scenario and it remains my preferred scenario . It's not a prediction, but I'd like everyone to start talking about this "head and shoulders" pattern .

We break down, maybe test the 200- day moving average, or even break it, then we drop to the year-to-date pivot point, and then we do this. And then , when everyone starts talking about the very obvious head and shoulders pattern, it turns out to be a trap for bears.

We go back up here and then start building for the next upward push by the end of the year. Not a prediction, but definitely my favorite scenario. I love it when we get that failed hack first.

Brian ShannonPublished 2026-11-10
“Nvidia Getting Throttled, Is Jensen Huang a Double Agent? TraderTV Live 11/10/26”
$XBINo side taken
Brian ShannonPublished 2026-11-06
“Stock Market, Bitcoin, Gold Analysis for Week Ending 11/6/26”
$XBINo side taken
AI summary · XBI's bounce stalled below a downward-trending 50-day moving average and it appears to be forming a clear head-and-shoulders top. The speaker expects a break below the neckline, sees a continued decline from there as unlikely, and considers a short-seller trap followed by a turn back up the more typical path, though not guaranteed; if it breaks down and keeps falling, be careful.

Biotechs also failed to move close to the 50-day moving average. This is what I told subscribers yesterday, that yes, we are seeing some bounce, but our 5-day moving average is still down.

Our 50-day moving average is also trending downward.

I think there could be a nice situation here and you can see I've drawn it , this is one shoulder, this is one head and this is the other shoulder. In fact, it's such a clear pattern that I think what's probably going to happen is it's going to come down , break the neckline here, and then everyone who's read technical analysis books will say, hey, that made a big top. It formed a Head and Shoulders pattern.

Brian ShannonPublished 2026-10-06
“Brian Shannon on TraderTV 10/6/26”
$XBIBearish
AI summary · XBI trend is bearish with lower highs/lows and broken support; potential drop to 146.5-147 in coming week means no rush to buy.

A name, or perhaps more of a sector I know you often look at; You have given us a few great individual names. I know you mentioned the ETF, and that is biotech. There are many names here that you have mentioned for swing trades and the like.

You gave us a few . I believe that even CRISPR and that sort of thing are names you have given us. Maybe I'm wrong, but what about the XBI today?

What they said to watch for
Steve MillerPublished 2026-09-11
“askSlim Market Week Brief 09/11/26 - Analysis of Financial Markets”
$XBINo side taken
AI summary · XBI faces a short-term pullback to 144-150 but remains poised for new highs by year-end.

Okay, so this is the XBI on the intermediate term. It has been rising. It has been acting great. Every flag has turned up on the upside here as you can see right here and right there.

But now we are starting to really stall out a little bit versus that 170 area.

97 to about 1019 is when that low is due. What is happening with this overall translation really really strong? This is a right-hand translation where we have used up most of that cycle rallying.

It's it is leaving a short window of time for a pullback after which we would be looking for still new highs uh here as we get out out likely into year end uh in the XBI.

Brian ShannonPublished 2026-08-21
“Stock Market & Crypto Analysis for Week Ending 8/21/26”
$XBIBullish
AI summary · XBI is likely to reach a new all-time high near 175, about 9 points above current levels.

And of course, the big move this week was in the biotech stocks. They look like they're magnetized to the new to a new all-time high up in here. That would bring this XBI up to 175 basically.

Another 10 points higher from you know, 9 points higher from here. And like I said, it seems magnetized to there.

That's the earliest record
All updates for other tickers
Follow $XBI30-day free trial
Start trial